Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Research and Practice in Thrombosis and Haemostasis|September 2, 2025
Factor XIII deficiency due to compound heterozygosity for 2 <i>F13A1</i> variantsJodie Odame, Caroline Malcolmson, Cindy Wakefield, et al.Journal of Thrombosis and Haemostasis : JTH|December 21, 2019
Patients with aortic stenosis have von Willebrand factor abnormalities and increased proliferation of endothelial colony forming cellsSoundarya N Selvam, Mackenzie Bowman, Madeline Inglis, et al.Blood Advances|October 18, 2018
A decreased and less sustained desmopressin response in hemophilia A carriers contributes to bleedingVictoria Candy, Hilary Whitworth, Julie Grabell, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|July 10, 2023
Impact of transcatheter aortic valve implantation on circulating von Willebrand factor in patients with severe aortic stenosisSonu S Varghese, Marie-France Hetu, Mackenzie Bowman, et al.Journal of Thrombosis and Haemostasis : JTH|July 13, 2020
Endothelial characteristics in healthy endothelial colony forming cells; generating a robust and valid ex vivo model for vascular diseaseSuzan de Boer, Mackenzie Bowman, Colleen Notley, et al.Blood Advances|September 19, 2022
A transcriptome analysis of basal and stimulated VWF release from endothelial cells derived from patients with type 1 VWDRobert Kloosterman, Matteo Zago-Schmitt, Julie Grabell, et al.Journal of Thrombosis and Haemostasis : JTH|April 25, 2022
von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cellsMackenzie Bowman, Lara Casey, Soundarya N Selvam, et al.Blood|April 18, 2009
A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3Megan S Sutherland, Anthony M Cumming, Mackenzie Bowman, et al.BMJ Open|April 17, 2025
Genomic testing for bleeding disorders (GT4BD): protocol for a randomised controlled trial evaluating the introduction of whole genome sequencing early in the diagnostic pathway for patients with inherited bleeding disorders as compared with standard of careMegan Chaigneau, Mackenzie Bowman, Julie Grabell, et al.Journal of Thrombosis and Haemostasis : JTH|July 14, 2026
Evaluation of the determinants of FVIII/FIX levels, bleeding score, and health-related quality of life in the Canadian hemophilia carriers (CHiC) studyLaura L Swystun, Julie Grabell, Megan Hinds, et al.Pageof 2